In an unexpected policy pivot, the FDA is tightening the reins on COVID vaccine access by limiting new approvals to those over 65 and other high‐risk groups. Critics argue that while the move may streamline regulatory efforts, it effectively sidelines a broader segment of the public—leaving many with fewer options.
Back to Top / Tuesday, May 20, 2025, 4:20 pm / permalink 5114 / 2 stories in 9 months
Vaccine panel rejects COVID shot prescription requirement / 5 months
Vaccine Advisory Panel Cancels Combined MMRV Shot Recommendation / 5 months
CDC Leadership Ouster Sparks Chaos in Federal Health Agency / 6 months
RFK Jr. decisively fires entire CDC vaccine panel amid controversy / 8 months
New MAHA report sparks debate over US children’s health policies / 5 months
Florida Moves to End State Vaccine Mandates / 6 months
CDC Director Ousted Weeks Into Job / 6 months
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.